Search results for " market"
Webcast
Establishing a CHO-K1 cell line and cell line development process for biotherapeutics markets
Establishing a robust cell line is a critical step in the development of a biotherapeutic. But how can you meet rapid timelines when the cell line development workflow is challenged by documentation…
Article
Webinar: Establishing a CHO-K1 cell line and cell line development process for biotherapeutics markets
Establishing a robust cell line is a critical step in the development of a biotherapeutic. But how can you meet rapid timelines when the cell line development workflow is challenged by doc…
Article
Increasing mRNA capabilities and capacity for growing market needs
The rapid development of innovative vaccines allowed for the pharmaceutical industry to deliver its first tools in the fight against the COVID-19 pandemic.
READ FULL ARTICLE >>
Article
Accelerating an Orphan Therapy to Market
Click here to learn more >>
This case study shares the work of Cytiva’s Fast Trak Services team to help accelerate development of a process for cGMP production of material for toxicology studies.…
Article
The Bullish Outlook for Biosimilars
During the past few years, questions about the underlying technology and market acceptance have begun to resolve themselves in a positive manner. Regulatory pathways are being defined, and major playe…
Article
Drugs, At What Cost?
In 2012, developed markets (United States, Japan, Germany, France, Italy, Spain, United Kingdom, Canada, and South Korea) reduced spending for the first time due to patent expirations, austerity measu…
Article
Biotechnology Innovation and Growth in Israel
Despite these changes, however, the Israeli pharmaceutical market is still expected to grow.
In 1995, Israel enacted a National Health Insurance Act, granting basic health insurance …
Article
The Affordable Care Act's Impact on Innovation in Biopharma
Within this uncertain market, what is obvious is that the industry is in the midst of significant transition. Critical drivers of this change are largely macroeconomic; policy is simply accelerating c…
Article
Challenges and Trends in Biopharma Facility Design
“Global deployment, cost pressure, time to market, and change/uncertainty” are some of the factors biopharma companies need to consider, according to Par Almhem, president of Modwave. And, the trend t…
Article
Trends in BioPharma Approvals in 2013
This annual approval rate was equalled only in 2009, a year in which 20 new products came on the market (see Figure 1).
Products…